Security file · CUSIP 64125C109
NBIX
NEUROCRINE BIOSCIENCES INC · US listing · held by 2 tracked managers in Q3 2026.
Tracked holders · Q3 2026
2
+1 vs Q2 2026
Aggregate reported value
$781M
sum of holders' reported positions
New holders this quarter
1
0 added · 1 trimmed
Holder return since filing
-0.3%
weighted by each holder's position share · since filing
Ownership · Q3 2026
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox Fundsfiled 13 Nov ET | 0.42% | 5.50M | -1.4% | $167 | -0.3% | $781M | Trimmed |
| 2 | Polen Capital Managementfiled 13 Nov ET | 0.00% | 1,595 | new | $167 | -0.3% | $226K | New |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2026 | 2 | +1 | $781M | 5.51M |
| Q2 2026 | 1 | +0 | $941M | 5.58M |
| Q1 2026 | 1 | +0 | $719M | 5.46M |
| Q4 2025 | 1 | +0 | $781M | 5.51M |
| Q3 2025 | 1 | +0 | $780M | 5.56M |
| Q2 2025 | 1 | +0 | $700M | 5.57M |
| Q1 2025 | 1 | +0 | $612M | 5.53M |
| Q4 2024 | 1 | +0 | $412M | 3.02M |
| Q3 2024 | 1 | +0 | $148M | 1.29M |
| Q2 2024 | 1 | +0 | $176M | 1.28M |
| Q1 2024 | 1 | +0 | $175M | 1.27M |
| Q4 2023 | 1 | +0 | $166M | 1.26M |
| Q3 2023 | 1 | — | $24.03M | 214K |